STEP analysis of macro-environmental factors affecting medical and drug care for patients with chronic myeloid leukemia

Objective: to conduct a STEP analysis (social, technological, economic, political) of macro-environmental factors influencing medical and drug care for patients with chronic myeloid leukemia (CML).

Material and methods. The materials used were information from the official website of the Federal State Statistics Service of the Russian Federation (RF), financial reports of the Ministry of Finance of the RF, the Ministry of Industry of the RF, the Federal Customs Service of the RF, the Federal Treasury, the All-Russian Center for the Study of Public Opinion, data from the World Health Organization and the Ministry of Health of the RF, regulatory framework of the RF, data from the State Register of Medicines of the RF and information from domestic and foreign scientific publications. The object of the study was the Department of Hematology and Chemotherapy of the Regional Clinical Hospital No. 1 (Tyumen). Structural, statistical, analytical, situational-logical, mathematical, graphic methods, as well as content analysis, STEP analysis and ranking were used.

Results. Providing medical and drug care to CML patients today is a vital and pressing problem in Russia and around the world. The effectiveness of pharmacotherapy directly depends on certain environmental factors, and each of them influences the functioning of a medical organization (MO) to varying degrees. Analysis of social factors made it possible to trace the dynamics and make a forecast regarding the capabilities of patients and MOs as well as the demand for drug therapy. Economic factors are based on the level of monetary income of the population and the expenditures of the RF budget on healthcare. The role of Russian export and import volumes is shown, first and foremost, the influence of these indicators on domestic prices, demand and on the macro-economic balance in general. Сreditor indebtedness changes the MO financial position and reflects the efficiency of using the monetary resources. Analysis of technological factors allowed assessing the equipment of the MO with medical facilities and drugs. The influence of such factors as the registration of new drugs for the treatment of CML patients and the digitalization program in health care was studied. Based on the analysis of political factors, the state’s interest in the development of domestic medicine and pharmacy was determined.

Conclusion. The STEP analysis of external factors influencing medical and drug care for CML patients allowed identifying the most significant ones for optimizing pharmacotherapy in this category of patients, which is relevant for medical practice and the pharmaceutical industry.

1. Khanakhmedova M.Kh. PEST analysis of the activities of a commercial organization. Innivatsii. Nauka. Obrazovanie / Innovations. Science. Education. 2020; 16: 600–3 (in Russ.).

2. Filobokova L.Yu. SNW-, STEP- and SWOT-analysis in the system of strategic management of small businesses. Economic Analysis: Theory and Practice. 2007; 17: 36–9 (in Russ.).

3. Slushkina E.Yu. Study of factors of the external macro and micro environment of the industrial enterprise. Economics and Business: Theory and Practice. 2022; 12 (2): 153–8 (in Russ.). https://doi.org/10.24412/2411-0450-2022-12-2-153-158.

4. Chronic myeloid leukemia. Clinical guidelines. 2020. Available at: https://cr.minzdrav.gov.ru/recomend/142_1 (in Russ.) (accessed 06.22.2023).

5. Yagudina R.I., Kulikov A.Yu., Komarov I.A. Cost-utility analysis over use of tyrosine kinase inhibitors (tasigna and gleevec) for treatment of chronic myeloid leukemia in the chronic phase as first-line therapy for de novo patients. FARMAKOEKONOMIKA. Sovremennaya farmako- ekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2013; 6 (3): 10–6 (in Russ.).

6. Plotnikova T.N., Rusakov G.N. Factors of the public health service development as a social-economic subsystem. The Siberian Aerospace Journal. 2009; 1-2: 120–3 (in Russ.).

7. russian Statistical Yearbook 2022. Federal State Statistics Service. Available at: https://rosstat.gov.ru/folder/210/document/12994 (in Russ.) (accessed 06.06.2023).

8. Kudusova M.I., Martynova M.A. Technological progress in medicine. Forum molodykh uchenykh / Forum of Young Scientists. 2018; 12: 1251–6 (in Russ.).

9. Hughes T.P., Mauro M.J., Cortes J.E., et al. Asciminib in chronic myeloid leukemia after abl kinase inhibitor failure. N Engl J Med. 2019; 381 (24): 2315–26. https://doi.org/10.1056/NEJMoa1902328.

10. Massaro F., Molica M., Breccia M. Ponatinib: a review of efficacy and safety. Curr Cancer Drug Targets. 2018; 18 (9): 847–56. https://doi.org/10.2174/1568009617666171002142659.

11. Zenina M.N., Shilova E.R., Chernysh N.Y. Modern hematological analyzers – opportunities and limitations. The Bulletin of Hematology. 2021; 17 (4): 24–31 (in Russ.).

12. Order of the Ministry of Health of the RF of 15.11.2012 No. 930n “On approval of the Procedure for providing medical care to the population in the field of hematology”. Available at: https://base.garant.ru/70357248/ (in Russ.) (accessed 22.06.2023).

13. Healthcare in Russia. 2021. Federal State Statistics Service. Available at: https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf (in Russ.) (accessed 23.06.2023).

14. Bozutinib. Registration certificate LP-№(002227)-(РГ-RU). The State Register of Medicines. Available at: https://grls.minzdrav.gov.ru/ Grls_View_v2.aspx?routingGuid=b8d2e7c3-fee8-41ea-9cbdb2619aa3d329 (in Russ.) (accessed 06.07.2023).

15. Global strategy on digital health 2020–2025. World Health Organization. Available at: https://www.who.int/docs/default-source/documents/gs4dhdaa2a9f352b0445bafbc79ca799dce4d.pdf (accessed 06.07.2023).

16. Ulumbekova G.E., Ginoyan A.B., Kalashnikova A.V., Alvianskaya N.V. Healthcare financing in Russia (2021–2024). Facts and suggestions. Healthcare Management. News. Views. Education. 2019; 5 (4): 4–19 (in Russ.). https://doi.org/10.24411/2411-8621-2019-14001.

17. Obukhova O.V., Sychev Yu.P., Kadyrov F.N., Bazarova I.N. Accounts payable of medical organizations operating in the compulsory health insurance system. Manager Zdravoochranenia. 2021; 10: 77–83 (in Russ.). https://doi.org/10.21045/1811-0185-2021-10-77-83.

18. The list of instructions following the meeting with representatives of the public in the Svetlogorsk city, Kaliningrad region. Available at: http://www.kremlin.ru/acts/assignments/orders/62571 (in Russ.) (accessed 12.06.23).

19. Implementation of additional sanctions against Russia and Belarus under the Export Administration Regulations (EAR) and refinements to existing controls. A Rule by the Industry and Security Bureau on 05/23/2023. Federal Register. Available at: https://www.federalregister.gov/documents/2023/05/23/2023-10774/implementation-of-additionalsanctions-against-russia-and-belarus-under-the-export-administration (accessed 12.06.23).

20. Order of the Ministry of Health of the RF of 19.05.2022 No. 339n “On the Interdepartmental Commission for determining the defect or risk of defect of medicines, issuing conclusions on determining the defect or risk of defect of medicines, on the possibility (impossibility) of temporary circulation of a series (batch) of an unregistered medicinal product and on the possibility (impossibility) of circulation in the Russian Federation of a series (batch) a medicinal product in a package intended for circulation in the territory of foreign states, medicinal products, in respect of which there is a defect or risk of its occurrence, in connection with the introduction of restrictive economic measures against the Russian Federation, as well as on the approval of the forms of these conclusions”. Available at: https://www.garant.ru/products/ipo/prime/doc/404655465/#review (in Russ.) (accessed 12.06.23).

21. The list of potentially defective drugs includes 86 drugs. Pharmaceutical Bulletin. Available at: https://pharmvestnik.ru/content/news/Vspisok-potencialno-defekturnyh-lekarstv-voshli-86-preparatov.html (in Russ.) (accessed 12.06.2023).

22. Krivenko N.V., Epaneshnikova D.S. The influence of imports phaseout in pharmaceutical industry on the increase in healthcare system efficiency and in socio-demographic security of the region. International Research Journal. 2020; 9-1: 180–7 (in Russ.). https://doi.org/100.23670/IRJ.2020.99.9.031.

23. Prices, inflation. Federal State Statistics Service. Available at: https://rosstat.gov.ru/statistics/price (in Russ.) (accessed 16.06.2023).

24. Income, expenses and savings of the population. Standard of living. Federal State Statistics Service. Available at: https://rosstat.gov.ru/folder/13397 (in Russ.) (accessed 16.06.2023).

25. Information on the indicator of the complex of process measures “The share of overdue accounts payable of budgets of subjects of the Russian Federation and local budgets in expenditures of consolidated budgets of constituent entities of the Russian Federation" by constituent entities of the Russian Federation. The Ministry of Finance of Russia. Available at: https://minfin.gov.ru/ru/document/?id_4=135602informatsiya_o_pokazatele_kompleksa_protsessnykh_meropriyatii_dolya_prosrochennoi_kreditorskoi_zadolzhennosti_byudzhetov_subektov_rossiiskoi_federatsii_i_mestnykh_byudzhetov_ (in Russ.) (accessed 16.06.2023).

26. Finance of Russia 2022. Federal State Statistics Service. Available at: https://rosstat.gov.ru/folder/210/document/13237 (in Russ.) (accessed 20.06.2023).

27. russia's import of essential goods. Federal Customs Service. Available at: https://customs.gov.ru/folder/515 (in Russ.) (accessed 22.06.2023).

28. russia's exports of essential goods. Federal Customs Service. Available at: https://customs.gov.ru/statistic/eksport-rossii-vazhnejshixtovarov (in Russ.) (accessed 22.06.2023).

29. Foreign trade of the Russian Federation (according to customs statistics). Federal State Statistics Service. Available at: https://rosstat.gov.ru/statistics/vneshnyaya_torgovlya (in Russ.) (accessed 22.06.2023).

30. Healthcare in Russia. 2021. Federal State Statistics Service. Available at: https://rosstat.gov.ru/storage/mediabank/ Zdravoohran-2021.pdf (in Russ.) (accessed 23.06.2023).

31. Reporting on budget execution. The Federal Treasury. Available at: https://roskazna.gov.ru/ispolnenie-byudzhetov/ (in Russ.) (accessed 22.06.2023).

32. Finance of Russia 2022. Statistical collection. Federal State Statistics Service. Available at: https://rosstat.gov.ru/storage/ mediabank/Finans_2022.pdf (in Russ.) (accessed 23.06.2023).

33. A guide to sanctions and restrictions against the Russian Federation (after February 22, 2022). Available at: https://base.garant.ru/57750632/#block_3192 (in Russ.) (accessed 07.07.2023).

34. Federal Law of 01.05.2022 No. 129-FZ “On amendments to the Law of the Russian Federation ‘On transplantation of human organs and (or) tissues’ and the Federal Law ‘On the basics of public health protection in the Russian Federation’ ”. Available at: https://base.garant.ru/404561946/ (in Russ.) (accessed 12.07.2023).

35. Bone marrow donation: ignorance creates stereotypes. All-Russian Center for the Study of Public Opinion. Available at: https://wciom.ru/expertise/donorstvo-kostnogo-mozga-neznanie-rozhdaet-stereotipy (in Russ.) (accessed 12.07.2023).

36. Decree of the President of the Russian Federation of 06.06.2019 No. 254 “On the Strategy for the development of healthcare in the Russian Federation for the period up to 2025”. Available at: http://www.kremlin.ru/acts/bank/44326 (in Russ.) (accessed 12.07.2023).

37. National projects “Healthcare” and “Demography”. The Ministry of Health of the RF. Available at: https://minzdrav.gov.ru/poleznye-resursy/natsproektzdravoohranenie (in Russ.) (accessed 08.09.2023).